David A Griffith

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Cardiovascular Disease

Glycemic Control

Top Venues

Nature medicine

The Journal of organic chemistry

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Chris Limberakis, Aaron C Smith, Scott W Bagley, Hatice G Yayla, Daniel W Kung, David A Griffith
Convergent Syntheses of Isomeric Imidazolospiroketones as Templates for Acetyl-CoA Carboxylase (ACC) Inhibitors. The Journal of organic chemistry (2023)
David A Griffith, David J Edmonds, Jean-Philippe Fortin, Amit S Kalgutkar, J Brent Kuzmiski, Paula M Loria, Aditi R Saxena, Scott W Bagley, Clare Buckeridge, John M Curto, David R Derksen, João M Dias, Matthew C Griffor, Seungil Han, V Margaret Jackson, Margaret S Landis, Daniel Lettiere, Chris Limberakis, Yuhang Liu, Alan M Mathiowetz, Jayesh C Patel, David W Piotrowski, David A Price, Roger B Ruggeri, David A Tess
A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor. Journal of medicinal chemistry 65 (12) (2022)
Aditi R Saxena, Donal N Gorman, Ryan M Esquejo, Arthur Bergman, Kristin Chidsey, Clare Buckeridge, David A Griffith, Albert M Kim
Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial. Nature medicine 27 (6) (2021)